No association between rheumatoid arthritis, amyotrophic lateral sclerosis, and tumour necrosis factor inhibitor treatment

被引:3
|
作者
Arkema, Elizabeth V. [1 ]
Feltelius, Nils [2 ,3 ]
Olsson, Tomas [4 ]
Askling, Johan [1 ,2 ]
机构
[1] Karolinska Inst, Dept Med, Clin Epidemiol Unit, S-17176 Stockholm, Sweden
[2] Karolinska Inst, Dept Med, Rheumatol Unit, S-17176 Stockholm, Sweden
[3] Med Prod Agcy, Uppsala, Sweden
[4] Karolinska Inst, Dept Clin Neurosci, S-17176 Stockholm, Sweden
关键词
TNF-ALPHA;
D O I
10.1136/annrheumdis-2014-205622
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:2061 / +
页数:2
相关论文
共 50 条
  • [21] Tumour necrosis factor antagonist use and associated risk reduction of cardiovascular events among patients with rheumatoid arthritis
    Greenberg, Jeffrey D.
    Kremer, Joel M.
    Curtis, Jeffrey R.
    Hochberg, Marc C.
    Reed, George
    Tsao, Peter
    Farkouh, Michael E.
    Nasir, Adeel
    Setoguchi, Soko
    Solomon, Daniel H.
    ANNALS OF THE RHEUMATIC DISEASES, 2011, 70 (04) : 576 - 582
  • [22] Intra-articular electrotransfer of mouse soluble tumour necrosis factor receptor in a murine model of rheumatoid arthritis
    Denys, Anne
    Thiolat, Allan
    Descamps, Delphyne
    Lemeiter, Delphine
    Benihoud, Karim
    Bessis, Nakacha
    Boissier, Marie-Christophe
    JOURNAL OF GENE MEDICINE, 2010, 12 (08) : 659 - 668
  • [23] Effects of Tumour Necrosis Factor Antagonists on Insulin Sensitivity/Resistance in Rheumatoid Arthritis: A Systematic Review and Meta-Analysis
    Burska, Agata N.
    Sakthiswary, Rajalingham
    Sattar, Naveed
    PLOS ONE, 2015, 10 (06):
  • [24] Secukinumab after anti-tumour necrosis factor- therapy: a phase III study in active rheumatoid arthritis
    Dokoupilova, E.
    Aelion, J.
    Takeuchi, T.
    Malavolta, N.
    Sfikakis, P. P.
    Wang, Y.
    Rohrer, S.
    Richards, H. B.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2018, 47 (04) : 276 - 281
  • [25] Interleukin 10 and Tumor Necrosis Factor-α Genotypes in Rheumatoid Arthritis - Association with Clinical Response to Glucocorticoids
    de Paz, Banesa
    Alperi-Lopez, Mercedes
    Ballina-Garcia, Francisco J.
    Prado, Catuxa
    Mozo, Lourdes
    Gutierrez, Carmen
    Suarez, Ana
    JOURNAL OF RHEUMATOLOGY, 2010, 37 (03) : 503 - 511
  • [26] Baseline tumour necrosis factor alpha levels predict the necessity for dose escalation of infliximab therapy in patients with rheumatoid arthritis
    Takeuchi, Tsutomu
    Miyasaka, Nobuyuki
    Tatsuki, Yoshihiko
    Yano, Toshiro
    Yoshinari, Toru
    Abe, Tohru
    Koike, Takao
    ANNALS OF THE RHEUMATIC DISEASES, 2011, 70 (07) : 1208 - 1215
  • [27] Association between serum tumour necrosis factor-α concentrations and chronic obstructive pulmonary disease
    Xiong, Xiao-feng
    Wei, Jia
    Lin, Yi-hua
    Cheng, De-yun
    CURRENT SCIENCE, 2016, 110 (02): : 172 - 179
  • [28] Association between tumour necrosis factor-a polymorphism and cervical cancer in Lagos State, Nigeria
    John-Olabode, Sarah
    Udenze, Ifeoma C.
    Adejimi, Adebola A.
    Ajie, Obiefuna
    Okunade, Kehinde S.
    ECANCERMEDICALSCIENCE, 2025, 19
  • [29] The association between urbanization and rheumatoid arthritis in Taiwan
    Chiang, Yi-Chun
    Yen, Yu-Hsuan
    Chang, Wei-Chiao
    Cheng, Kuei-Ju
    Chang, Wei-Pin
    Chen, Hsiang-Yin
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2016, 54 (01) : 1 - 10
  • [30] Newly Synthesized Indolylacetic Derivatives Reduce Tumor Necrosis Factor-Mediated Neuroinflammation and Prolong Survival in Amyotrophic Lateral Sclerosis Mice
    Corvino, Angela
    Caliendo, Giuseppe
    Fiorino, Ferdinando
    Frecentese, Francesco
    Valsecchi, Valeria
    Lombardi, Giovanna
    Anzilotti, Serenella
    Andreozzi, Giorgia
    Scognamiglio, Antonia
    Sparaco, Rosa
    Perissutti, Elisa
    Severino, Beatrice
    Gargiulo, Michele
    Santagada, Vincenzo
    Pignataro, Giuseppe
    ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE, 2024, : 1996 - 2005